Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
May 5, page 58: The 19th Winter Fluorine Conference will feature an award address by the winner of the 2009 ACS Award for Creative Work in Fluorine Chemistry, whose name has yet to be announced, not the 2008 winner.
There is irony in the book review “Finding Jobs in Biopharma” (C&EN, May 19, page 48). The image is of a researcher at Immunex, a company subsumed (and essentially dismantled) by Amgen several years back. Opportunities, indeed! I hope there’s a “pros and cons” discussion on when small start-ups are bought by big pharma.
Mary Beckman
Richland, Wash.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter